This is a preview of subscription content, log in via an institution to check access.
References
Shaunak S, Thornton M, John S, et al. Reduction of the viral load of HIV-1 after intraperitoneal administration of dextrin 2- sulphate in patients with AIDS. AIDS 1998 Mar 5; 12: 399–409
Stafford MK, Cain D, Rosentein I, et al. A placebo-controlled, double-blind prospective study in healthy female volunteers of dextrin sulphate gel. J Acquir Immune Defic Syndr Hum Retrovirol 1997 Mar; 14: 213–8
Rosenstein IJ, Stafford MK, Kitchen VS, et al. Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1. J Infect Dis 1998 May; 177: 1386–90
Shaunak S, Gooderham NJ, Edwards RJ, et al. Infection by HIV-1 blocked by binding of dextrin 2-sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T-cells. Br J Pharmacol 1994 Sep; 113: 151–8
Javan CM, Gooderham NJ, Edwards RJ, et al. Anti-HIV type 1 activity of sulfated derivatives of dextrin against primary viral isolates of HIV type 1 in lymphocytes and monocyte-derived macrophages. AIDS Res Hum Retroviruses 1997 Jul 1; 13: 875–80
Rights and permissions
About this article
Cite this article
Dextrin-2-Sulfate. Drugs R&D 2, 340–342 (1999). https://doi.org/10.2165/00126839-199902050-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00126839-199902050-00013